Johnson & Johnson (Auris Health)
About Johnson & Johnson (Auris Health)
Johnson & Johnson (Auris Health) is at the forefront of medical intervention, developing robotic platforms that enhance physician capabilities and evolve minimally invasive techniques. Their flagship Monarch Platform, initially focused on lung cancer, utilizes robotics, micro-instrumentation, endoscope design, sensing, and data science to improve diagnostic and therapeutic bronchoscopic procedures. This technology allows physicians to accurately access small and hard-to-reach lung nodules for early diagnosis and targeted treatment, a critical advancement given that lung cancer is the deadliest cancer globally, often due to late detection.
The company’s commitment extends to transforming surgical care through a connected digital ecosystem. This ecosystem aims to provide real-time insights to medical professionals before, during, and after procedures, leveraging AI-powered applications fueled by device, patient, and other surgical data. Johnson & Johnson MedTech is actively working with partners like NVIDIA to test new AI capabilities for this ecosystem, enabling continuous learning where algorithms improve based on data collected by deployed devices. This includes developing AI algorithms to analyze surgical video, create 3D maps for cardiac procedures, and assist in presurgical planning and real-time guidance via telepresence.
Beyond lung cancer, Auris Health’s technology is designed to be a modular platform with potential for expansion into other interventional applications, such as urology and ENT. The Monarch Platform for Urology, for example, is leveraging AI-driven simulation to create virtual operating room environments for procedure planning and training, and is expected to be commercially available in the U.S. in 2026. This comprehensive approach underscores Johnson & Johnson’s vision to be a leader across various surgical approaches, integrating robotics and digital solutions to enhance surgical performance and ultimately improve patient outcomes.
Focus Areas
Business Intelligence
| Key Investors | Coatue, Wellington, Partner Fund Management, Mithril Capital, Lux Capital, Viking Global Investors, D1 Capital Partners, Senator Investment Group, Highland Capital, NaviMed Capital, Nimble Ventures |
| Partnerships | Franciscan Health Cancer Center Indianapolis (for Monarch Platform deployment), Providence Mission Hospital (for Monarch Platform deployment) |
| Acquisitions | Hansen Medical (acquired by Auris Health in 2016); Auris Health acquired by Johnson & Johnson in 2019 |
| Technology | Monarch Platform (integrates robotics, micro-instrumentation, endoscope design, sensing, and data science; utilizes computer-assisted navigation based on 3D patient models) |
| FDA Clearances | 2 (Monarch Platform for bronchoscopic procedures, Monarch Platform for endourological procedures) cleared products (estimated) |
What Physicians Need to Know
For physicians, the Johnson & Johnson (Auris Health) MONARCH Platform offers unparalleled precision and control for navigating challenging anatomy in both bronchoscopy and urology. The system's ability to reach small, hard-to-reach nodules in the lungs enables earlier diagnosis and potentially more effective treatment of lung cancer. In urology, it provides enhanced visualization and control for kidney stone removal, potentially reducing retreatment rates and complications. The intuitive, controller-like interface and computer-assisted navigation, based on 3D patient-specific models, enhance procedural confidence and efficiency. The integration of data science and AI also suggests future enhancements for decision support and personalized medicine.
Johnson & Johnson is actively building a comprehensive digital ecosystem that integrates Auris Health's technology with other robotic platforms, such as the OTTAVA Robotic Surgical System, and Ethicon's surgical instrumentation. This strategy aims to provide a unified approach across various surgical specialties, from open and laparoscopic to robotic and endoluminal procedures. The MONARCH platform is designed to be a modular, software-enabled platform, allowing for extensions into other clinical indications beyond its initial focus.
What the Web Says
Johnson & Johnson (Auris Health) generally receives positive to mixed reviews, particularly for its Monarch Platform, which is praised for its innovative technology in robotic-assisted bronchoscopy. Employer reviews indicate a large corporate environment with opportunities for growth, but also highlight challenges related to bureaucracy and integration post-acquisition.
Overall: MixedStrengths
- Monarch Platform is innovative and improves diagnostic capabilities for lung cancer.
- Advanced robotic technology for minimally invasive procedures.
- Opportunities for career growth within a large, established company.
- Strong focus on medical technology and patient outcomes.
- Competitive compensation and benefits.
- Positive impact on healthcare through advanced medical devices.
Limitations
- Integration challenges and cultural shifts post-acquisition by Johnson & Johnson.
- Bureaucracy and slow decision-making typical of a large corporation.
- Work-life balance can be challenging due to demanding schedules.
- Some employees report feeling like a small part of a very large machine.
- Limited specific product reviews on general platforms like G2/Capterra, more specialized healthcare IT reviews.
- Potential for high pressure in a fast-paced medical device environment.
Based on reviews from: Glassdoor, Reddit, Healthcare IT News (general industry sentiment), Specialized medical device review sites (implied from product mentions), G2 (limited specific product reviews), Capterra (limited specific product reviews)
Last updated: 2026-08-24
Videos
News, demos, and interviews about Johnson & Johnson (Auris Health).
Videos load interactively. If none appear, search YouTube for Johnson & Johnson (Auris Health) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]